Drug Profile
Buprenorphine oral - Orexo
Alternative Names: OX-382Latest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator Orexo
- Class Cyclopropanes; Drug withdrawal therapies; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor agonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Opioid-related disorders; Pain
Most Recent Events
- 06 Nov 2020 Suspended - Preclinical for Pain in Sweden (PO) as company intends to explore new formulation opportunities
- 04 Nov 2020 Suspended - Phase-I for Opioid-related disorders in Sweden (PO) as company intends to explore new formulation opportunities
- 08 Jun 2018 Chemical structure information added